Sociodemographic Barriers to the Timely Treatment of Pancreatic Cancer.
| Autor: | Jimenez PB; University of Puerto Rico School of Medicine, San Juan, Puerto Rico; paola.berrios2@upr.edu., Popp R; University of Florida College of Medicine, Gainesville, FL, U.S.A., Sharan S; Government Medical College and Hospital, Chandigarh, India., Manaise HK; Government Medical College and Hospital, Chandigarh, India., Ahmed SH; Dow University of Health Sciences, Karachi, Pakistan., Bansal S; Government Medical College and Hospital, Chandigarh, India., Kowkabany G; The University of Alabama, Tuscaloosa, AL, U.S.A., Raikot S; Mayo Clinic, Rochester, MN, U.S.A., DO KBS; Duke University Medical Center, Durham, NC, U.S.A., George A; Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, U.S.A., Gabriel E; Department of General Surgery, Division of Surgical Oncology, Mayo Clinic Florida, Jacksonville, FL, U.S.A. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Anticancer research [Anticancer Res] 2023 Nov; Vol. 43 (11), pp. 4969-4974. |
| DOI: | 10.21873/anticanres.16695 |
| Abstrakt: | Background/aim: Pancreatic cancer has a high mortality rate and timely treatment is imperative for favorable patient outcomes. This retrospective study aimed to identify disparities in time to treatment for pancreatic cancer based on sociodemographic factors. Patients and Methods: The study used the National Cancer Database from 2004 to 2019. A total of 423,482 patients with pancreatic cancer were included in the study. Time to first treatment, surgery, radiation, and chemotherapy were analyzed in the context of age, sex, race, Hispanic origin, insurance status, income, facility type, geographic setting, grade, stage, and Charlson-Deyo Comorbidity score (CDC). Results: All sociodemographic factors included were found to be significantly associated with disparities for time to treatment in at least one of the categories studied. Minorities, treatment at academic facilities, and patients with a high CDC score had consistently longer times to all treatment classifications. Conclusion: The analyzed sociodemographic factors affected time to pancreatic cancer treatment. Disparities in time to treatment for pancreatic cancer must be studied and understood to ameliorate the impact this cancer has on society and assure the best possible care for all communities. (Copyright © 2023, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|